Ophthalmic Devices are those devices which are used for vision correction or in ophthalmic diagnostic interventions. Glaucoma Surgery Devices are used to augment normal physiologic aqueous outflow pathways in order to provide effective intra-ocular pressure. GlobalData uses proprietary data and analytics to provide a comprehensive report on the glaucoma surgery devices devices market, including market shares of different players within Japan. Buy the latest report here.
In 2023, GlobalData’s Market Model methodology determined that the leading player in the glaucoma surgery devices market in Japan was Glaukos followed by Allergan Aesthetics, Alcon, Johnson & Johnson Vision Care, Santen Pharmaceutical, Aurolab and Nova Eye Medical.
Glaucoma Surgery Devices include Glaucoma Drainage Devices and Minimally Invasive Glaucoma Surgery (MIGS) Devices. Glaucoma Drainage Devices are designed to divert aqueous humor from the anterior chamber to an external reservoir, where a fibrous capsule forms about 4-6 weeks after surgery and regulates flow. MIGS is an ab interno procedure which is carried out using micro-incisions. MIGS Devices are usually less than 1mm
The value of the glaucoma surgery devices devices market within Japan was expected to be over $10m in 2023.
For the latest complete market share analysis of glaucoma surgery devices device market in Japan, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.